Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,025 | Dovepress* | 8,372+ | 905 | 9,277 | |
| PubMed Central* | 653 | 166 | 819 | ||
| Totals | 9,025 | 1,071 | 10,096 | ||
| *Since 25 June 2018 | |||||
View citations on PubMed Central and Google Scholar